- Home
- COLL vs PFBC Comparison
COLL vs PFBC Comparison
Compare COLL & PFBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- PFBC
- Stock Information
- Founded
- COLL 2002
- PFBC 1991
- Country
- COLL United States
- PFBC United States
- Employees
- COLL N/A
- PFBC 323
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- PFBC Major Banks
- Sector
- COLL Health Care
- PFBC Finance
- Exchange
- COLL Nasdaq
- PFBC Nasdaq
- Market Cap
- COLL 958.8M
- PFBC 1.1B
- IPO Year
- COLL 2015
- PFBC 1998
- Fundamental
- Price
- COLL $30.35
- PFBC $91.46
- Analyst Decision
- COLL Strong Buy
- PFBC Hold
- Analyst Count
- COLL 4
- PFBC 3
- Target Price
- COLL $43.75
- PFBC $92.33
- AVG Volume (30 Days)
- COLL 283.6K
- PFBC 100.2K
- Earning Date
- COLL 08-07-2025
- PFBC 07-24-2025
- Dividend Yield
- COLL N/A
- PFBC 3.28%
- EPS Growth
- COLL N/A
- PFBC N/A
- EPS
- COLL 1.25
- PFBC 9.43
- Revenue
- COLL $664,283,000.00
- PFBC $265,954,000.00
- Revenue This Year
- COLL $20.04
- PFBC $0.53
- Revenue Next Year
- COLL $3.98
- PFBC $4.01
- P/E Ratio
- COLL $24.19
- PFBC $9.70
- Revenue Growth
- COLL 17.17
- PFBC N/A
- 52 Week Low
- COLL $23.23
- PFBC $71.90
- 52 Week High
- COLL $42.29
- PFBC $99.78
- Technical
- Relative Strength Index (RSI)
- COLL 54.25
- PFBC 71.24
- Support Level
- COLL $29.28
- PFBC $84.74
- Resistance Level
- COLL $30.83
- PFBC $87.91
- Average True Range (ATR)
- COLL 0.75
- PFBC 2.11
- MACD
- COLL -0.00
- PFBC 0.86
- Stochastic Oscillator
- COLL 51.63
- PFBC 100.00
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About PFBC Preferred Bank
Preferred Bank is a commercial bank located in California. Its products and services are divided into Personal Banking, Business Banking, and Commercial Banking which includes Checking accounts, Savings accounts, CDs, Loans and Credit, Electronic banking, and Treasury Management. It provides personalized deposit services, real estate finance, commercial loans, and trade finance credit facilities to small and mid-sized businesses and their owners, entrepreneurs, real estate developers and investors, professionals, and high-net-worth individuals. The bank generates a majority of its revenue from Southern and Northern California and Flushing.